Comparing safety information of biosimilars with their originators: a cross‐sectional analysis of European risk management plans

BACKGROUND AND AIMS: Biosimilars have been available in the European Union (EU) since 2006. However, their uptake in routine care is heterogeneous across countries. The aim of the present study was to compare the safety information of biosimilars and their originators based on the information in the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Clin Pharmacol
Главные авторы: Lepelaars, Leroy R. A., Renda, Francesca, Pani, Luca, Pimpinella, Giuseppe, Leufkens, Hubert G. M., Trifirò, Gianluca, Tafuri, Giovanni, Mantel‐Teeuwisse, Aukje K., Trotta, Francesco
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Drug Safety
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5867080/
https://ncbi.nlm.nih.gov/pubmed/29164665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13454
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы